Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tracon Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Tracon Pharmaceuticals

Tracon Pharmaceuticals

Public

US-based TRACON Pharmaceuticals develops and commercializes targeted therapeutics for cancer and age-related diseases.

HQ
San Diego, CA, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Founded in San Diego, TRACON Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel targeted therapeutics for cancer and age-related diseases. The company's core mission is to address unmet medical needs by leveraging endoglin biology to create antibodies that bind to the endoglin receptor. TRACON's lead product candidate, envafolimab, is a PD-L1 antibody aimed at treating sarcoma, positioning the company within the oncology and age-related disease markets.

TRACON Pharmaceuticals has garnered attention through its innovative approach and strategic focus on targeted therapies. Notable figures affiliated with the company include its experienced leadership team and scientific advisors who bring extensive expertise in biopharmaceutical development. The company has achieved significant milestones, including advancing envafolimab through clinical trials. Overall, TRACON's impact lies in its potential to offer new therapeutic options for patients with cancer and other serious conditions, contributing to the advancement of medical science in these critical areas.

Tracon Pharmaceuticals - Similar Companies

Tallac Therapeutics logo

Tallac Therapeutics

Trana Discovery logo

Trana Discovery

Tract Therapeutics logo

Tract Therapeutics

Crinetics Pharmaceuticals logo

Crinetics Pharmaceuticals

crinetics.com

Trilo Therapeutics logo

Trilo Therapeutics

Trefoil Therapeutics logo

Trefoil Therapeutics

Trancura Biosciences logo

Trancura Biosciences

Trio Pharmaceuticals logo

Trio Pharmaceuticals

Tradewind BioScience logo

Tradewind BioScience

tradewindbio.com

Travere Therapeutics logo

Travere Therapeutics

travere.com

Trevena logo

Trevena

Tactiva Therapeutics logo

Tactiva Therapeutics

Tr1x logo

Tr1x

tr1x.bio

Adcentrx Therapeutics logo

Adcentrx Therapeutics

adcentrx.com

Janux Therapeutics logo

Janux Therapeutics

januxrx.com

Tracon Pharmaceuticals - Quick Facts

Who are Tracon Pharmaceuticals' competitors?

Companies similar to Tracon Pharmaceuticals include Tallac Therapeutics, Trana Discovery, Tract Therapeutics and Crinetics Pharmaceuticals.

When was Tracon Pharmaceuticals founded?

Tracon Pharmaceuticals was founded in 2004.

Where is Tracon Pharmaceuticals' headquarters located?

Tracon Pharmaceuticals' headquarters is located in San Diego, CA, US.

When was Tracon Pharmaceuticals' last funding round?

Tracon Pharmaceuticals' most recent funding round was for $30M (USD) in December 2022.

How much has Tracon Pharmaceuticals raised to-date?

As of Dec 27, 2022, Tracon Pharmaceuticals has raised a total of $113M (USD).

How many employees does Tracon Pharmaceuticals have?

Tracon Pharmaceuticals has 18 employees as of Feb 6, 2024.

Tracon Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Antibodies
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research